Subscriptions are live: We're on the subscription model now, early-access price $24.99/month, with day, week, and longer plans too. New accounts start with 5 free premium days. Prefer to donate? Donations grant premium time and are logged on your profile page.

Plans & pricing
Donate for premium time
Logo
Sign In

$IPHA

Innate Pharma S.A. ADS

XNAS

$2.16+24.86%+$0.4300Prev $1.73LIVE Full chart Live alerts
No recent price bars, the chart lights up when IPHA starts printing.

Why is IPHA up today? It is at $2.16 (+24.86%), and our scanner flagged it 14 times on unusual volume this month. See the catalyst behind the move, real-time alerts the moment IPHA spikes, and full due diligence on IPHA — key stats, earnings, dilution and insider activity. Free.

Free alerts

Get free $IPHA alerts the moment volume spikes

Our scanner flagged $IPHA 14 times in the last 30 days. Create a free account to track $IPHA, build a watchlist, and get instant unusual-volume alerts — plus 5 free premium days, no card needed.

Real-time RVOL & momentum alerts Personal watchlist & price alerts
Sign up free with email

No card · 5 premium days · join 800+ traders

Key Stats

Price & performance
Price
$2.16
Change today
+24.86%
Previous close
$1.73
52-week range
$1.17 – $2.62
Valuation & dividend
Market cap
$162M
Ownership & volume
Shares outstanding
93.7M
SEC 20-F · Apr 1, 2026 ↗
Insider ownership
<1%
20-F · 2026-04-01 ↗
Institutional own.
0.22%
Total held
1.1%
Tradeable float
92.7M
99% of shares · after <1% insiders + 0% institutions
Short interest
164K
▼ -9% vs prior · as of 2026-07-15
Short % of float
0.2%
Days to cover
22.8d
Avg daily volume
76K
Classification
Exchange
XNAS
Relative volumevs this time of day
5mthin
230x
15mthin
100x
1hthin
360x
1D
270x

Get free IPHA + market alerts in your inbox

The top plays and unusual-volume catches our scanner flags, emailed to you. No account needed.

No spam. Unsubscribe anytime. Not investment advice.

Why is $IPHA up today?

14 alerts today4.5x RVOLSEC filing

IPHA is one of today's most active names, trading on unusually heavy volume (live price and day move above). Our scanner has fired 14 unusual-volume and momentum alerts on IPHA today, peaking at 4.5x its normal volume. Fresh from the SEC: Innate Pharma SA filed a Foreign issuer report (6-K). A material company disclosure like this is often the real catalyst behind a move of this size.

Likely catalystClinical / FDA update, from the latest SEC filing. Read it →
Why is $IPHA moving? →▶ Replay the moveAuto-generated from live scanner data. Not investment advice.
Trading profileNot shortableNo SSRBorrow via Alpaca · SSR from Reg SHO 201
Wall Street consensusStrong Buy2 analysts
Avg target $6.50(+201% upside)
Range $5 – $8
2 buy0 hold0 sell

Analyst data via Nasdaq. Not investment advice.

$IPHA Sentiment

Bullish
Bearish100Bullish
📰 News: 2 bull · 0 bearToday: +24.9%👥 Community: 0 bull · 0 bear

Blend of news sentiment, today’s move, and community votes. Not investment advice.

$IPHA Activity

News, unusual-volume alerts, AI-trader trades and community chatter — the whole story, newest first.

Alert· 51m ago -1.84%
$IPHA moved -1.84% in 1 min (Level 1) at 5:50 AM ET
at $2.19
Alert· 1h ago
The Watcher BOUGHT $IPHA at $2.1600 __THOTH_JSON__{"side":"buy","strategyLabel":"The Watcher · day","reason":"Add at level","shares":76,"instance":"Rider"}
at $2.16
Alert· 1h ago
The Watcher BOUGHT $IPHA at $2.1500 __THOTH_JSON__{"side":"buy","strategyLabel":"The Watcher · day","reason":"Add at level","shares":38,"instance":"Rider"}
at $2.15
Alert· 1h ago
The Watcher SOLD $IPHA at $2.3100 __THOTH_JSON__{"side":"sell","strategyLabel":"The Watcher · scalp","reason":"Scale out into strength","shares":8,"instance":"Rider","setup":"breakout-coil"}
at $2.31
Alert· 1h ago
The Watcher BOUGHT $IPHA at $2.2200 __THOTH_JSON__{"side":"buy","strategyLabel":"The Watcher · scalp","reason":"scalp entry · breakout-coil","shares":13,"instance":"Rider","setup":"breakout-coil"}
at $2.22
Alert· 1h ago +8.92%
$IPHA moved +8.92% (~15m high-low range 8.92%) (Level 5) at 4:58 AM ET
at $2.31
Alert· 1h ago 4.5× RVOL
IPHA hit 4.502x RVOL at 4:58 AM ET
at $2.30
Alert· 1h ago
The Watcher SOLD $IPHA at $2.2200 __THOTH_JSON__{"side":"sell","strategyLabel":"The Watcher · day","reason":"Scale out into strength","shares":45,"instance":"Rider","setup":"topplay-first(5m)"}
at $2.22
Alert· 1h ago +1.40%
$IPHA moved +1.40% in 1 min (Level 1) at 4:53 AM ET
at $2.15
Alert· 1h ago
The Watcher BOUGHT $IPHA at $2.1300 __THOTH_JSON__{"side":"buy","strategyLabel":"The Watcher · day","reason":"day entry · topplay-first(5m)","shares":70,"instance":"Rider","setup":"topplay-first(5m)"}
at $2.13
Alert· 1h ago
The Watcher SOLD $IPHA at $2.0500 __THOTH_JSON__{"side":"sell","strategyLabel":"The Watcher · scalp","reason":"stop_hit","shares":225,"instance":"Rider"}
at $2.05
Alert· 2h ago
The Watcher BOUGHT $IPHA at $2.2621 __THOTH_JSON__{"side":"buy","strategyLabel":"The Watcher · scalp","reason":"scalp entry · topplay-first(1m)","shares":225,"instance":"Rider","setup":"topplay-first(1m)"}
at $2.26
Alert· 2h ago +13.79%
$IPHA moved +13.79% in 1 min (Level 5) at 4:01 AM ET
at $2.62
Alert· 2h ago 3.1× RVOL
IPHA hit 3.129x RVOL at 4:01 AM ET
at $2.48
News· SEC EDGAR· 4h ago
Innate Pharma SA filed a Foreign issuer report (6-K)
News· SEC EDGAR· 18d ago
Innate Pharma SA filed a Foreign issuer report (6-K)
News· SEC EDGAR· 20d ago
Innate Pharma SA filed a Foreign issuer report (6-K)
News· Benzinga· 68d ago Neutral
A Third Cancer Drug Just Entered the Clinic at an Under-$20-Million Company
News· SEC EDGAR· 80d ago
Innate Pharma SA filed a Foreign issuer report (6-K)
News· GlobeNewswire Inc.· 80d ago Bullish
Cutaneous T-Cell Lymphoma Clinical Trial Pipeline Accelerates as 30+ Pharma Companies Rigorously Developing Drugs for Market Entry | DelveInsight
News· GlobeNewswire Inc.· 104d ago Bullish
Peripheral T-Cell Lymphoma Market to Witness Significant Expansion at a CAGR of 7% During the Forecast Period (2026–2036) Amid Advancing Treatment Landscape | DelveInsight
News· GlobeNewswire Inc.· 276d ago Neutral
Arvind Sood joins Coherus Oncology as Chief Strategy and Corporate Affairs Officer

Also moving today

The tickers our scanner is lighting up most over the last 48 hours.

$SOAR$JWEL$INHD$ZJYL$YYAI$STKH$XHLD$WYHG$STFS$DKI$VIVS$SPCX

IPHA stock FAQ

Why is $IPHA up today?

IPHA is one of today's most active names, trading on unusually heavy volume (live price and day move above). Our scanner has fired 14 unusual-volume and momentum alerts on IPHA today, peaking at 4.5x its normal volume. Fresh from the SEC: Innate Pharma SA filed a Foreign issuer report (6-K). A material company disclosure like this is often the real catalyst behind a move of this size.

What is the IPHA stock price today?

IPHA last traded at $2.16, up 24.86% on the day. The price and chart above update live during market hours (4 AM to 8 PM ET).

Where can I see live IPHA alerts?

The IPHA Live Alerts panel on this page streams real-time unusual volume (RVOL), momentum, halt and 200-EMA alerts from our scanner the moment they fire. Our scanner has flagged IPHA 14 times in the last 30 days.

What exchange is IPHA on?

IPHA (Innate Pharma S.A. ADS) trades on XNAS, with a market cap of about $162M.

Is IPHA good for day trading?

That depends on your strategy and risk. Day traders look for volume, volatility and a clear trend. Use the live chart, RVOL alerts and 200-EMA context on this page to judge IPHA for yourself. This is not investment advice.

Live data from TheDesperateTrader scanner. Not investment advice.